Article info
Hepatology
Original research
S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development
- Correspondence to Professor Michelangelo Foti, Department of Cell Physiology and Metabolism, University of Geneva Faculty of Medicine, Geneve 1206, Switzerland; michelangelo.foti{at}unige.ch
Citation
S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development
Publication history
- Received May 3, 2019
- Revised December 19, 2019
- Accepted December 20, 2019
- First published January 9, 2020.
Online issue publication
September 07, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.